Disorders of Hemostasis |
* Molecular Pathology Laboratory, Christchurch School of Medicine and Health Sciences, University of Otago, Christchurch, New Zealand
° Canterbury Health Laboratories, Canterbury Hospital, Christchurch, New Zealand
# The Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI, USA
@ The Ohio State University College of Medicine Department of Pediatrics and Childrens Hospital, Columbus, OH, USA
Correspondence: Ryan Davis, Molecular Pathology Laboratory, Christchurch School of Medicine and Health Sciences, University of Otago, P.O. Box 4345, Christchurch, New Zealand. Phone: international +64.33640552. Fax: international +64.33640545. E-mail: ryan.davis{at}chmeds.ac.nz
Fibrinogen is an essential component of the coagulation cascade and the acute phase response. The native 340 kDa molecule has a symmetrical trinodular structure composed of a central E-domain connected to outer D-domains by triple helical coiled-coils.1 Several mutations known to cause hypofibrinogenemia occur within the C-terminal gammaD-domain and have helped to elucidate the structurally and functionally important areas of this domain.2–5 Here we report the identification of a novel point mutation gammaG200V (fibrinogen Columbus) causing hypofibrinogenemia and cosegregating with three genetic thrombophilia risk factors.